Neuca S.A. (NEU) - Total Assets

Latest as of December 2025: zł6.24 Billion PLN ≈ $1.72 Billion USD

Based on the latest financial reports, Neuca S.A. (NEU) holds total assets worth zł6.24 Billion PLN (≈ $1.72 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check NEU cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Neuca S.A. - Total Assets Trend (2005–2025)

This chart illustrates how Neuca S.A.'s total assets have evolved over time, based on quarterly financial data. Explore Neuca S.A. long-term investment allocation to see how much of total assets are deployed in long-term investments.

Neuca S.A. - Asset Composition Analysis

Current Asset Composition (December 2025)

Neuca S.A.'s total assets of zł6.24 Billion consist of 66.9% current assets and 33.1% non-current assets.

Asset Category Amount (PLN) % of Total Assets
Cash & Equivalents zł0.00 2.2%
Accounts Receivable zł2.00 Billion 32.1%
Inventory zł1.93 Billion 30.9%
Property, Plant & Equipment zł0.00 0.0%
Intangible Assets zł162.01 Million 2.6%
Goodwill zł1.04 Billion 16.6%

Asset Composition Trend (2005–2025)

This chart illustrates how Neuca S.A.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Neuca S.A..

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Neuca S.A.'s current assets represent 66.9% of total assets in 2025, a decrease from 88.7% in 2005.
  • Cash Position: Cash and equivalents constituted 2.2% of total assets in 2025, up from 1.5% in 2005.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 18.0% of total assets, an increase from 0.0% in 2005.
  • Asset Diversification: The largest asset category is accounts receivable at 32.1% of total assets.

Neuca S.A. Competitors by Total Assets

Key competitors of Neuca S.A. based on total assets are shown below.

Company Country Total Assets
Sigma Healthcare Ltd
AU:SIG
Australia AU$8.74 Billion
Jointown Pharmaceutical Group Co Ltd
SHG:600998
China CN¥112.28 Billion
AKSO HEALTH GR. (SPADR)/3
F:8HX
Germany €212.04 Million
Arjo AB (publ)
ST:ARJO-B
Sweden Skr14.98 Billion
Ebos Group Ltd
AU:EBO
Australia AU$8.80 Billion
Paragon Care Ltd
AU:PGC
Australia AU$1.31 Billion
Mayne Pharma Group Ltd
AU:MYX
Australia AU$1.01 Billion
Cyclopharm Ltd
AU:CYC
Australia AU$46.10 Million

Neuca S.A. - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.89 0.95 0.98
Quick Ratio 0.48 0.52 0.53
Cash Ratio 0.00 0.00 0.00
Working Capital zł-512.99 Million zł-203.51 Million zł-58.20 Million

Neuca S.A. - Advanced Valuation Insights

This section examines the relationship between Neuca S.A.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 3.04
Latest Market Cap to Assets Ratio 0.15
Asset Growth Rate (YoY) 13.3%
Total Assets zł6.24 Billion
Market Capitalization $905.29 Million USD

Valuation Analysis

Below Book Valuation: The market values Neuca S.A.'s assets below their book value (0.15x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Neuca S.A.'s assets grew by 13.3% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Neuca S.A. (2005–2025)

The table below shows the annual total assets of Neuca S.A. from 2005 to 2025.

Year Total Assets Change
2025-12-31 zł6.24 Billion
≈ $1.72 Billion
+13.28%
2024-12-31 zł5.51 Billion
≈ $1.52 Billion
+6.47%
2023-12-31 zł5.18 Billion
≈ $1.42 Billion
+6.94%
2022-12-31 zł4.84 Billion
≈ $1.33 Billion
+17.56%
2021-12-31 zł4.12 Billion
≈ $1.13 Billion
+14.16%
2020-12-31 zł3.61 Billion
≈ $992.44 Million
+5.71%
2019-12-31 zł3.41 Billion
≈ $938.82 Million
+9.48%
2018-12-31 zł3.12 Billion
≈ $857.51 Million
+7.07%
2017-12-31 zł2.91 Billion
≈ $800.86 Million
+8.12%
2016-12-31 zł2.69 Billion
≈ $740.71 Million
+0.37%
2015-12-31 zł2.68 Billion
≈ $737.95 Million
+4.35%
2014-12-31 zł2.57 Billion
≈ $707.18 Million
+33.99%
2013-12-31 zł1.92 Billion
≈ $527.77 Million
+2.45%
2012-12-31 zł1.87 Billion
≈ $515.13 Million
-4.99%
2011-12-31 zł1.97 Billion
≈ $542.19 Million
-5.25%
2010-12-31 zł2.08 Billion
≈ $572.26 Million
+2.54%
2009-12-31 zł2.03 Billion
≈ $558.08 Million
+50.11%
2008-12-31 zł1.35 Billion
≈ $371.78 Million
+18.26%
2007-12-31 zł1.14 Billion
≈ $314.37 Million
+110.15%
2006-12-31 zł543.57 Million
≈ $149.60 Million
+46.41%
2005-12-31 zł371.26 Million
≈ $102.18 Million
--

About Neuca S.A.

WAR:NEU Poland Medical Distribution
Market Cap
$905.29 Million
zł3.29 Billion PLN
Market Cap Rank
#9533 Global
#45 in Poland
Share Price
zł730.00
Change (1 day)
+1.96%
52-Week Range
zł649.00 - zł850.00
All Time High
zł953.88
About

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic an… Read more